Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00284752
Status:
COMPLETED
Last Update Posted:
2012-10-01
First Post:
2006-01-30
Brief Title:
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer
Sponsor:
Kaiser Permanente
Organization:
Kaiser Permanente